Good Doctor·Hot Infusion | Successfully held the first 2025 annual application training class for hot infusion therapy machines

From April 12th to 13th, 2025, Xi’an Good Doctor Medical Science and Technology Co., Ltd. successfully held the "2025 First-Phase Hyperthermia Perfusion Treatment Machine Application Training Course." This training attracted numerous agents and aimed to further enhance agents' understanding and application capabilities of the body cavity hyperthermia perfusion treatment machine, strengthen cooperation between the two parties, and jointly promote the widespread application of body cavity hyperthermia perfusion treatment technology in the medical field.

This body cavity hyperthermia perfusion treatment machine application training is an important measure for Xi’an Good Doctor Medical Science and Technology Co., Ltd. to promote the popularization of body cavity hyperthermia perfusion treatment technology. This training featured rich content, diverse formats, a combination of theory and practice, and a teaching team composed of expert professors with over ten years of experience in controlling postoperative metastasis and resolving malignant ascites, as well as experienced clinical treatment and professional engineers.

During the training, the lecturers provided in-depth explanations of the basic theories and characteristics of product knowledge, helping trainees build a solid knowledge framework. By sharing clinical application cases, the advantages of the product in practical applications were analyzed in detail, giving trainees a more intuitive understanding of the product's value. Finally, the training moved to hands-on operation, with on-site demonstrations, training assessments, and competitions to test the trainees' practical skills.

During the training, trainees engaged in focused discussions on the course content, actively raised questions, exchanged experiences, and received on-site answers to their questions. A lively atmosphere was maintained throughout the two-day learning and exchange. Ultimately, all trainees passed the assessment and successfully obtained their training completion certificates.

Tumor cells are more sensitive to temperature changes than normal cells. In the temperature range of 40-43℃, the metabolic processes of tumor cells are significantly disrupted, cell membrane permeability changes, leading to cell internal environmental imbalance, and thus inducing tumor cell apoptosis. At the same time, the warm environment can enhance the cytotoxic effect of chemotherapeutic drugs, promoting better penetration of the drugs into the interior of tumor cells and improving the efficacy of chemotherapy. Good Doctor body cavity hyperthermia perfusion technology, as a green and innovative auxiliary treatment method for tumors, has significant advantages, especially suitable for clinical department application. The Good Doctor body cavity circulation hyperthermia perfusion system has five outstanding advantages:

Good Applicability: Micro-creation of dual channels, usable in both internal medicine and surgery.

Good Safety: Precise and stable temperature and flow rate, safe and controllable with multiple protections.

Good Thermal Drug Properties: Constant temperature circulation hyperthermia chemotherapy, uniform distribution and high thermal sensitivity.

Good Selectivity: Diversified perfusion modes, multiple choices for prevention and treatment range.

Good Operability: Easy-to-master equipment operation, easy to perform repeatedly.

The Good Doctor body cavity hyperthermia perfusion machine is technologically leading in the industry and can achieve functions such as: "constant temperature, multiple treatment modes, small capacity of hyperthermia perfusion circulation tubing, dynamic balance, and constant temperature high-flow rate circulation." This equipment can meet the needs of different stages before, during, and after surgery, as well as multi-cavity treatment, with advantages such as minimal invasiveness, metastasis control, and ascites treatment. By achieving the synergistic effect of chemotherapy drugs and hyperthermia, it effectively prolongs patients' lives and improves their quality of life.

Practical Value of Good Doctor Body Cavity Hyperthermia Perfusion Technology:

Minimal trauma, can be used in conjunction with minimally invasive pre-placed puncture needles and drainage tubes to achieve effective circulation.

Suitable for the treatment of malignant body cavity ascites caused by thoracic and abdominal cancers and for the prevention of postoperative metastasis.

Can be used repeatedly multiple times according to the chemotherapy cycle.

Precise multi-channel temperature monitoring in the thoracic and abdominal cavities.

External tubing capacity less than 500ml, facilitating precise clinical medication.

Can be used in conjunction with a detachable filter to ensure the removal of cancer cells.

Wide range of applications, convenient for multi-department use.

Features multi-channel temperature monitoring with multiple inputs and outputs.

Features high-flow rate flushing during surgery.

Features automatic drainage of intraoperative perfusion fluid.

Suitable for the treatment of advanced or progressive thoracic and abdominal cancers.

External tubing capacity less than 500ml, facilitating precise clinical medication.

Can be used with thoracoscopy and laparoscopy to perform hyperthermia perfusion treatment.

Can be used in conjunction with a detachable filter to ensure the removal of cancer cells.

With the successful conclusion of the 2025 First-Phase Hyperthermia Perfusion Treatment Machine Application Training Course, the cooperative ties between us and our agents are becoming increasingly strong. The successful holding of this training course has not only deepened everyone's understanding of body cavity hyperthermia perfusion technology but has also injected new impetus into the widespread promotion of this technology in the medical market.

The Good Doctor management team has 25-30 years of clinical medical work experience and maintains a high sense of responsibility and mission, providing scientific, innovative, and practical professional solutions for people who "prevent and treat tumor body cavity implantation metastasis and treat cancerous ascites." It also provides professional technical support and high-quality services to partners.

In the future, the company will continue to strive for breakthroughs in technology, continuously innovate, and actively carry out various academic and application training activities. Relying on its unique advantages, it will take root and grow in the medical field. At the same time, it will further strengthen communication and cooperation with agents to jointly develop the market. Through the joint efforts of all parties, we will allow body cavity hyperthermia perfusion technology to be understood and used by more medical institutions, contributing more to improving China's tumor treatment level and improving patients' quality of life.